Plc Glaxosmithkline's Net Worth
Plc Glaxosmithkline's net worth is estimated to be at least $29,987,594,372,074.92 as of 12/23/2024. CoreStreet's estimation of Plc Glaxosmithkline's net worth is based on their sale of stock and current holding of stock.
Plc Glaxosmithkline is Major Shareholder at GlaxoSmithKline PLC ADR. They have executed at least 28 trades of stock as per SEC Form 4 filings. Their most recent trade was for 32,005,260 units of GSK stock on 05/20/2021. Their biggest sale was on 05/20/2021 when they sold 32,005,260 units of GlaxoSmithKline PLC ADR stock for $392,064,435.00. They typically trade 3 times per year.
Total value of insider buys:
- $29,986,939,456,430.00
Total value of insider sells:
- $654,915,644.92
Most recent insider trade:
- May 20, 2021
Plc Glaxosmithkline's Insider Trading History
| GlaxoSmithKline PLC ADR | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
May 20, 2021 | Major Shareholder | 32,005,260 | $12.25 | Sell | $392,064,435.00 |
July 21, 2020 | Director | 361,111 | $18.00 | Buy | $6,499,998.00 |
Oct. 18, 2019 | Major Shareholder | 357,142 | $28.00 | Buy | $9,999,976.00 |
Sept. 10, 2019 | Director | 177,777 | $45.00 | Buy | $7,999,965.00 |
July 1, 2019 | Director | 333,333 | $15.00 | Buy | $4,999,995.00 |
May 28, 2019 | Director | 385,714 | $14.00 | Buy | $5,399,996.00 |
April 22, 2019 | Director | 325,000 | $18.00 | Buy | $5,850,000.00 |
July 30, 2018 | Insider | 148,818 | $11.00 | Buy | $1,636,998.00 |
July 17, 2018 | Major Shareholder | 80,000 | $12.50 | Buy | $1,000,000.00 |
July 2, 2018 | Major Shareholder | 269,230 | $13.00 | Buy | $3,499,990.00 |
Nov. 6, 2017 | Major Shareholder | 428,571 | $14.00 | Buy | $5,999,994.00 |
Oct. 24, 2016 | Major Shareholder | 66,500 | $14.00 | Buy | $931,000.00 |
| Decibel Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Feb. 17, 2021 | Director | 150,000 | $18.00 | Buy | $2,700,000.00 |
| Nkarta Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
July 14, 2020 | Director | 833,333 | $18.00 | Buy | $14,999,994.00 |
| Bicycle Therapeutics Ltd | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
July 14, 2020 | Major Shareholder | 1,597 | $19.27 | Sell | $30,774.19 |
| Progyny Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
May 20, 2020 | Major Shareholder | 4,000,000 | $25.75 | Sell | $103,000,000.00 |
| ChemoCentryx Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Oct. 16, 2018 | Insider | 7,343,492 | $11.69 | Sell | $85,845,421.48 |
| Liquidia Technologies Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
July 30, 2018 | Insider | 148,818 | $11.00 | Buy | $1,636,998.00 |
| Spero Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
July 17, 2018 | Major Shareholder | 80,000 | $12.50 | Buy | $1,000,000.00 |
Nov. 6, 2017 | Major Shareholder | 428,571 | $14.00 | Buy | $5,999,994.00 |
| HTG Molecular Diagnostics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
March 27, 2017 | Insider | 300,000 | $10.15 | Sell | $3,045,000.00 |
| Theravance Biopharma Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
March 14, 2016 | Major Shareholder | 1,301,015 | $23,028,000.00 | Buy | $29,959,773,420,000.00 |
Oct. 7, 2015 | Major Shareholder | 44,574 | $607,544.00 | Buy | $27,080,666,256.00 |
| Applied Genetic | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Feb. 23, 2015 | Major Shareholder | 503,150 | $22.00 | Sell | $11,069,300.00 |
| Amicus Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Oct. 27, 2014 | Major Shareholder | 11,315,825 | $5.29 | Sell | $59,860,714.25 |
Nov. 20, 2013 | major shareholder | 1,500,000 | $2.00 | Buy | $3,000,000.00 |
| Concert Pharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Feb. 19, 2014 | Major Shareholder | 35,000 | $14.00 | Buy | $490,000.00 |
| Genocea Biosciences Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Feb. 10, 2014 | Insider | 143,773 | $12.00 | Buy | $1,725,276.00 |